openPR Logo
Press release

Bringing Automation into Biobanks

05-17-2011 08:08 AM CET | Science & Education

Press release from: Select Biosciences

/ PR Agency: Alto Marketing
The World Biobanking Summit to join the European Lab Automation Conference Streams

Select Biosciences, organisers of European Lab Automation (ELA) 2011, is pleased to announce that the World Biobanking Summit will join the highly topical conference streams already confirmed at this unique laboratory automation conference and exhibition. With wide ranging and cutting edge discussion topics, Select Biosciences is offering the opportunity to initiate discussion at all levels of the Biobanking community.
The World Biobanking Summit is a well-established and respected conference and has been moving from strength to strength in recent years as a conference in its own right. As an integral part of the program for the European Lab Automation event, the World Biobanking Summit will discuss the challenges and successes associated with the storage of numerous sample types:
•Blood Banking
•Sample Storage and Collection
•Quality Assurance, Standardisation and Harmonisation of Biobanks
•Cancer Biobanking; Challenges, Opportunities and Developments
•Legal, Ethical and Regulatory Considerations
The symposium will allow delegates to discuss their current systems and processes, and is to be addressed by the keynote speakers Mary-Beth Fisk, Vice President of the Texas Blood and Tissue Bank who will discuss “Umbilical Cord Blood Collection, Processing and Storage”; and Malcolm Mason from Cardiff University, who will give a presentation entitled “Wither Biobanking for Cancer? Building Our Reserves or, a Spending Spree.”
Delegates are offered the chance to join in the planned program of events by presenting their work in this area in the form of a poster presentation, with a deadline for the submission of presentations of the 20th May 2011.
In addition to the Conference sessions included within delegate registration package, the following training courses and market tutorial are available for further registration:
•Introduction to Laboratory Automation
•Implementing Laboratory Automation in Biobanks and Biotech Labs
•Adult Stem Cells, Cord Blood Stem Cells and Cellular Therapy Market Tutorial
To find out more about what ELA has to offer scientists across the board, please email s.marsden@selectbiosciences.com or visit www.EuroLabAutomation.com.

Established in 1999, Select Biosciences provide event planning and consultancy services for the life science sector. A recipient of the 2010 Queens Award for International Trade, they provide a portfolio of over 40 events per year, focusing mainly on the drug discovery and development sectors.

Alto Marketing

Office 3 | Universal Marina | Crableck Lane | Sarisbury Green | Southampton | SO31 7AL | UK

Exhibit enquiries
Select Biosciences
Sam Marsden - Business Development Manager
t: +44 (0)1787 314955
e: s.marsden@selectbiosciences.com

Media enquiries
Alto Marketing Limited
Clare Jones – Account Director
t: +44 (0)1489 557672
e: clarej@alto-marketing.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bringing Automation into Biobanks here

News-ID: 175233 • Views:

More Releases from Select Biosciences

Select Biosciences Gears Up For ELA 2012
Europe’s leading laboratory automation conference and exhibition announced for 2012 Following the success of European Laboratory Automation (ELA) 2011, Select Biosciences has announced that it will be hosting next year’s conference and exhibition at the Congress Centre Hamburg (CCH), Germany, 30 - 31 May 2012. Registration for ELA 2012 is now open, and all delegates have the option to attend 8 different conference streams, each of which includes internationally
New European Lab Automation Event Saw Outstanding Success
Positive feedback establishes conference at the heart of European R&D The first European Lab Automation (ELA) conference and exhibition, which took place at the Congress Centre Hamburg (CCH), Germany last month was an outstanding success. With 1523 attendees and 151 exhibitors and media partners, the feedback was overwhelmingly positive. The combination of ten comprehensive conference streams and workshops provided useful and relevant scientific content across a range of applications within laboratory
Science and Innovation Celebrated at ELA with the Life Science Awards
Select Biosciences Celebrates those working at the Cutting Edge of Science Select Biosciences, are pleased to announce the winners of the inaugural Life Science Awards. Successful candidates were presented their awards by prestigious speakers and industry leaders at an evening ceremony, held at the Radisson Blu Hotel, Hamburg. The awards were a prelude to the first European Lab Automation (ELA) conference and exhibition, Europe’s first and largest event dedicated
Access to Europe's only Laboratory Automation Event
Select Biosciences offer the chance to register free for an exhibition only pass to ELA Select Biosciences, organisers of European Lab Automation (ELA) 2011, are providing the opportunity to register free to visit the exhibition at ELA, Europe’s only event dedicated to laboratory automation. The European Lab Automation event will take place at the Congress Centre Hamburg (CCH), 30 June – 1 July in Hamburg, Germany. To gain access to this

All 5 Releases


More Releases for Biobanking

Global Biobanking Services & Biobanking Software Market Size, Share, Growth, Tre …
The Biobanking Services Market has witnessed substantial growth in recent years, driven by increasing investments in research and development activities across the healthcare and life sciences sectors. Biobanks play a crucial role in collecting, storing, and managing biological samples, such as blood, tissues, and cells, along with associated clinical and genetic data. This market's size is expected to expand significantly in the coming years due to rising demand for personalized
Biobanking Market - Strength in Diversity, Defying Disease: Biobanking Fuelling …
Newark, New Castle, USA: The "Biobanking Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biobanking Market: https://www.growthplusreports.com/report/biobanking-market/7617 This latest report researches the industry structure, sales, revenue, price and
Mexico Biobanking Market Analysis to 2027
Biobanking Market: Overview Transparency Market Research (TMR) has published a new report on the biobanking market for the forecast period of 2019-2027. According to the report, the global biobanking market was valued at ~US$ 2 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Biobanking Market: Overview Growth of the global biobanking market is attributed to an increase in the demand for biobanks in genomics and biomedical research, and rising focus on precision medicine. North America dominated the
Biobanking Market Overview and Regional Outlook Study
Biobanking Market Introduction The term 'biobanking' is often misused to refer to any collection of human biological specimens (biospecimens), regardless of the standards established for various tissue collection procedures or requirements pertaining to ethical and legal considerations. The process of collecting bodily fluids or tissue samples for usage in research to better understand health and disease is referred to as biobanking. Biobank is a sizable collection of biospecimens that are kept
Biobanking Market: Rising Impressive Business Opportunities Analysis Forecast by …
(Latest Industry Report 2022) Biobanking Market report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The study provides a complex examination of the application, including a detailed cost assessment analysis of the products available in the global market with respect to the profit margins of established manufacturers.
Biobanking Market Industry Trends, Estimation & Forecast, 2017 - 2025
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market include a rise in funding support by private & government organizations. Furthermore, increased incidence of chronic disease further propel the market growth. However, ethical and legal issues related to biobanking restrict market growth. The major factors for the